251 related articles for article (PubMed ID: 27281650)
1. Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer.
Neugut AI; Zhong X; Wright JD; Accordino M; Yang J; Hershman DL
JAMA Oncol; 2016 Oct; 2(10):1326-1332. PubMed ID: 27281650
[TBL] [Abstract][Full Text] [Related]
2. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI
J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090
[TBL] [Abstract][Full Text] [Related]
3. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
Neugut AI; Subar M; Wilde ET; Stratton S; Brouse CH; Hillyer GC; Grann VR; Hershman DL
J Clin Oncol; 2011 Jun; 29(18):2534-42. PubMed ID: 21606426
[TBL] [Abstract][Full Text] [Related]
4. Risks of nonadherence to hormone therapy in Asian women with breast cancer.
Hsieh KP; Chen LC; Cheung KL; Yang YH
Kaohsiung J Med Sci; 2015 Jun; 31(6):328-34. PubMed ID: 26043413
[TBL] [Abstract][Full Text] [Related]
5. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Hershman DL; Shao T; Kushi LH; Buono D; Tsai WY; Fehrenbacher L; Kwan M; Gomez SL; Neugut AI
Breast Cancer Res Treat; 2011 Apr; 126(2):529-37. PubMed ID: 20803066
[TBL] [Abstract][Full Text] [Related]
6. Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors.
Yang J; Neugut AI; Wright JD; Accordino M; Hershman DL
J Oncol Pract; 2016 Aug; 12(8):e800-9. PubMed ID: 27407167
[TBL] [Abstract][Full Text] [Related]
7. Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
Wigertz A; Ahlgren J; Holmqvist M; Fornander T; Adolfsson J; Lindman H; Bergkvist L; Lambe M
Breast Cancer Res Treat; 2012 May; 133(1):367-73. PubMed ID: 22286315
[TBL] [Abstract][Full Text] [Related]
8. Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer.
Farias AJ; Du XL
J Clin Oncol; 2017 Jan; 35(1):86-95. PubMed ID: 28034069
[TBL] [Abstract][Full Text] [Related]
9. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
Calip GS; Elmore JG; Boudreau DM
Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
[TBL] [Abstract][Full Text] [Related]
10. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
Nekhlyudov L; Li L; Ross-Degnan D; Wagner AK
Breast Cancer Res Treat; 2011 Nov; 130(2):681-9. PubMed ID: 21842245
[TBL] [Abstract][Full Text] [Related]
11. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.
Simon R; Latreille J; Matte C; Desjardins P; Bergeron E
Can J Surg; 2014 Feb; 57(1):26-32. PubMed ID: 24461223
[TBL] [Abstract][Full Text] [Related]
12. Topical Estrogen Prescription Fill Rates for Women With a History of Breast Cancer Who Are Taking Hormone Therapy.
Huntley JH; Richter LA; Blackford AL; Aliu O; Pollack CE
Obstet Gynecol; 2018 Nov; 132(5):1137-1142. PubMed ID: 30303924
[TBL] [Abstract][Full Text] [Related]
13. Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk.
Pistilli B; Paci A; Ferreira AR; Di Meglio A; Poinsignon V; Bardet A; Menvielle G; Dumas A; Pinto S; Dauchy S; Fasse L; Cottu PH; Lerebours F; Coutant C; Lesur A; Tredan O; Soulie P; Vanlemmens L; Jouannaud C; Levy C; Everhard S; Arveux P; Martin AL; Dima A; Lin NU; Partridge AH; Delaloge S; Michiels S; André F; Vaz-Luis I
J Clin Oncol; 2020 Aug; 38(24):2762-2772. PubMed ID: 32568632
[TBL] [Abstract][Full Text] [Related]
14. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
[TBL] [Abstract][Full Text] [Related]
15. Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
Wassermann J; Gelber SI; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Come SE; Meyer ME; Partridge AH
Cancer; 2019 Sep; 125(18):3266-3274. PubMed ID: 31120571
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy use among Appalachian breast cancer survivors.
Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R
Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
Cavazza M; Banks H; Ercolanoni M; Cukaj G; Bianchi G; Capri G; Longo F
Breast Cancer Res Treat; 2020 Aug; 183(1):189-199. PubMed ID: 32591986
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
Blanchette PS; Lam M; Richard L; Allen B; Shariff SZ; Vandenberg T; Pritchard KI; Chan KKW; Louie AV; Desautels D; Raphael J; Earle CC
Breast Cancer Res Treat; 2020 Jan; 179(1):217-227. PubMed ID: 31571072
[TBL] [Abstract][Full Text] [Related]
19. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
Hwang GS; Paranjpe R; Opsomer C; Lu K; Abajue U; Abughosh S; Zaghloul H; Trivedi MV
Clin Breast Cancer; 2020 Dec; 20(6):520-526. PubMed ID: 32669209
[TBL] [Abstract][Full Text] [Related]
20. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
Ziller V; Kalder M; Albert US; Holzhauer W; Ziller M; Wagner U; Hadji P
Ann Oncol; 2009 Mar; 20(3):431-6. PubMed ID: 19150950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
